Inductive Quotient Analytics (IQA) is a ‘Clinical Trials (Biostatics, Data Management, Statistical Programming and Operations), Data Science’ (Big Data, AI, ML and IoT), and Product Development Company’. IQA also has Proprietary Products like Inductive EDC, Medical Screening, Volunteer Management Systems (VMS) and Projects Scheduling Systems, which are USFDA 21-CFR Part-11 compliant and cost-effective. IQA has an impressive track record having delivered 300 (+) BA/BE and 60 (+) Clinical Trials Studies (Phase I-IV) across the major & emerging therapeutic areas like oncology to its global customers. IQA is currently focusing on healthcare domain. As the healthcare organizations develop more sophisticated big data analytics capabilities, they are beginning to move from basic descriptive analytics towards the realm of predictive insights.
